Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma

J Clin Oncol. 2008 Mar 20;26(9):1569-71. doi: 10.1200/JCO.2007.15.4989.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abdominal Neoplasms / drug therapy*
  • Abdominal Neoplasms / pathology
  • Abdominal Neoplasms / surgery
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Coma / chemically induced*
  • Fatal Outcome
  • Female
  • Fibroma / drug therapy*
  • Fibroma / surgery
  • Fibrosarcoma / drug therapy*
  • Fibrosarcoma / secondary
  • Fibrosarcoma / surgery
  • Humans
  • Indoles / administration & dosage
  • Indoles / adverse effects*
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Middle Aged
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrroles / administration & dosage
  • Pyrroles / adverse effects*
  • Sunitinib
  • Treatment Failure

Substances

  • Antineoplastic Agents
  • Indoles
  • Protein Kinase Inhibitors
  • Pyrroles
  • Protein-Tyrosine Kinases
  • Sunitinib